Our Phase 1 Clinical Trial Centre and Bioavailability and Bioequivalence (BABE) Unit were accredited by the National Medical Products Administration (NMPA) since 2016 and 2006, respectively. It means that the clinical study data generated from our site will be accepted by the NMPA for registration purpose. Our data can also be submitted to the US, European and Japanese regulatory authorities.
Track Record
Our dedicated research team have conducted various pharmacokinetics/pharmacodynamics (PK/PD) studies, SAD/MAD studies, food-drug / drug-drug interaction studies, first in man studies and bioequivalence studies in the past on a wide range of medications including vaccines, dispersible tablets, aerosols, infusions, transdermal delivery systems and topical agents.
Our Collaborations
With our professional study team, we have collaborated with renowned pharmaceutial companies all over the world
